ANALYSIS TREATMENT OUTCOME OF 46 REFRACTORY/RELAPSED PEDIATRIC MATURE B CELL LYMPHOMA PATIENTS‐MULTI‐CENTER EXPERIENCE FROM CHINA.

MLA

Zhang, Y., et al. “Analysis Treatment Outcome of 46 Refractory/Relapsed Pediatric Mature B Cell Lymphoma Patients‐Multi‐Center Experience from China.” Hematological Oncology, vol. 41, June 2023, pp. 67–68. EBSCOhost, https://doi.org/10.1002/hon.3163_32.

APA

Zhang, Y., Huang, S., Jin, L., Yang, J., Hu, B., Zheng, C. M., Zhai, W. X., Wang, S. H., Li, F., Yang, X., Liu, A., Yuan, X., Liu, W., Zhang, L., Wang, J., Dai, Y., Sun, L., Zhou, C., & Gao, Z. (2023). Analysis Treatment Outcome of 46 Refractory/Relapsed Pediatric Mature B Cell Lymphoma Patients‐Multi‐Center Experience from China. Hematological Oncology, 41, 67–68. https://doi.org/10.1002/hon.3163_32

Chicago

Zhang, Y., S. Huang, L. Jin, J. Yang, B. Hu, C. M. Zheng, W. X. Zhai, et al. 2023. “Analysis Treatment Outcome of 46 Refractory/Relapsed Pediatric Mature B Cell Lymphoma Patients‐Multi‐Center Experience from China.” Hematological Oncology 41 (June): 67–68. doi:10.1002/hon.3163_32.